2013
DOI: 10.1016/j.ajem.2013.05.029
|View full text |Cite
|
Sign up to set email alerts
|

Myasthenia gravis and Guillain-Barré cooccurrence syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
11
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 14 publications
0
11
1
Order By: Relevance
“…3 To the best of our knowledge, the occurrence of MG and GBS overlap syndrome is quite rare. [3][4][5][6][7][8][9][10][11][12][13][14] Furthermore, only 4 studies have reported the comorbidity of MG and MFS previously. [15][16][17][18] Here, we review all previously described cases and present a new case of our own.…”
mentioning
confidence: 99%
“…3 To the best of our knowledge, the occurrence of MG and GBS overlap syndrome is quite rare. [3][4][5][6][7][8][9][10][11][12][13][14] Furthermore, only 4 studies have reported the comorbidity of MG and MFS previously. [15][16][17][18] Here, we review all previously described cases and present a new case of our own.…”
mentioning
confidence: 99%
“…It is also noted that this combination of disorders are more prevalent between Chinese people which may in part point to the possible genetic background and ethnicity as predisposing factors for this rare combination [4,5]. In this report, we have presented a case of MG, newly diagnosed during her severe exacerbation, with clues for GBS particularly facial palsy that lead to the diagnosis of GBS after several days of ICU admission.…”
Section: Introductionmentioning
confidence: 83%
“…Both diseases have different pathophysiology and the nature of the presentation. The appearance of both in the same individual is a rare entity and is often under-recognised [1]. So far, only 14 reports have been reported in which 15 cases have been diagnosed with the coexistence of MG and GBS.…”
Section: Introductionmentioning
confidence: 99%